Are Patients Who Develop Angioedema With ACE Inhibition at Risk of the Same Problem With AT1 Receptor Blockers?
Arch Intern Med. 2003;163:240-241.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Angioedema is a bradykinin-mediated side effect of angiotensin-converting enzyme (ACE) inhibition. Patients who are intolerant to ACE inhibitors for this reason, but would otherwise benefit from this treatment, might instead be switched to an AT1 angiotensin receptor blocker (ARB), which is now being reported to offer similar benefits in terms of end-organ protection. However, the recently published reports that suggest participation of kinins in the effects of ARBs via activation of the AT2 receptor have raised concern of possible repeat angioedema in such patients. We report our experience with 10 such cases in which patients with confirmed angioedema to ACE inhibition were safely switched to an ARB without problems.
A large number of clinical outcome trials have now established beyond doubt the benefits of ACE inhibition in terms of cardioprotection and nephroprotection, even for nonhypertensive patients with other cardiovascular risk factors. Accordingly, ACE inhibitors are part of the mandatory treatment . . . [Full Text of this Article]
RELATED LETTERS
Literature Reports of Angiotensin Receptor Antagonist–Induced Angioedema in Patients With a History of Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema
Michael J. Flais
Arch Intern Med. 2003;163(12):1488.
EXTRACT
| FULL TEXT
Angioedema and AT1 Receptor Blockers: Proceed With Caution
James A. MacLean and Paul J. Hannaway
Arch Intern Med. 2003;163(12):1488-1489.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use: Outcome After Switching to a Different Treatment
Cicardi et al.
Arch Intern Med 2004;164:910-913.
ABSTRACT
| FULL TEXT
Should Evidence-Based Proof of Efficacy as Defined for a Specific Therapeutic Agent be Extrapolated to Encompass a Therapeutic Class of Agents?
Antman and Ferguson
Circulation 2003;108:2604-2607.
FULL TEXT
Literature Reports of Angiotensin Receptor Antagonist-Induced Angioedema in Patients With a History of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
Flais
Arch Intern Med 2003;163:1488-1488.
FULL TEXT
Angioedema and AT1 Receptor Blockers: Proceed With Caution
MacLean and Hannaway
Arch Intern Med 2003;163:1488-1489.
FULL TEXT
|
